Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2011Cancer Epidemiology Biomarkers & Prevention

Genetic Variants in the LEPR , CRY1 , RNASEL , IL4 , and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality

View Full Paper
Ask AI
Bookmark
Share

Authors

DLDaniel W. LinCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South AfricaLFLiesel M. FitzGeraldUniversity of TasmaniaRFRong FuShanxi Medical University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lin et al. (2011) studied this question.

synapsesocial.com/papers/6a9eb96a596cbcc64e8c4c22https://doi.org/10.1158/1055-9965.epi-11-0236
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Preoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy2006 · 627 citations
  2. 2How Well Does the Gleason Score Predict Prostate Cancer Death? A 20-Year Followup of a Population Based Cohort in Sweden2006 · 167 citations
  3. 3Cumulative Association of Five Genetic Variants with Prostate Cancer2008 · 635 citations
  4. 4Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death1959 · 360 citations
  5. 5Susceptibility Loci Associated with Prostate Cancer Progression and Mortality2010 · 87 citations